Submissions

Login or Register to make a submission.

Author Guidelines

To submit a new paper to our journal:

  1. Register on the Journal website; we encourage you to register also as a Reviewer at the same time;
  2. Follow the Guidelines for Authors for preparation of your manuscript;
  3. Read our Editorial Policies and our Competing Interest policies.
  4. Log in;
  5. Click on the "NEW SUBMISSION" button to start the online procedure.

To submit a revised version:

  1. Log in;
  2. Click on the title of your paper;
  3. Next to the heading "REVISIONS", upload your revised paper by using the "UPLOAD FILE" button;
  4. Inform the Editors that a revised version has been uploaded.

Submission Preparation Checklist

All submissions must meet the following requirements.

  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor). While the manuscript is undergoing the peer review phase, the authors will not submit the manuscript to another journal without notifying the editor.
  • The submission file is in OpenOffice, Microsoft Word, RTF, or PDF document file format.
  • We fight plagiarism: please understand that your article will be checked with available tools for discovering plagiarism.
  • Authors are kindly required to suggest at least two potential reviewers (name, affiliation and e-mail) for their manuscript in the "Comments to the Editor" field (Step 1. Submission Process).
  • The text is double-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed at the end. If tables are used, they should be double spaced on separate pages. They should be numbered and cited in the text of the article. If abbreviations are used in the text, authors are required to write full name+abbreviation in brackets [e.g. Multiple Myeloma (MM)] the first time they are used, then only abbreviations can be written (apart from titles; in this case authors have to write always the full name).
  • Please read this advice and download associated files. The International Committee of Medical Journal Editors has recently published in all ICMJE journals an editorial introducing a new “Disclosure Form for Potential Conflict of Interest”, with the aim to establish uniform reporting system, which can go over the existing differences in current formats or editors’ requests. We at PAGEPress Publications welcome this initiative as a possible uniforming, standardizing way to have this important disclosure authorizing the publications of manuscripts. We are therefore asking you to duly fill in the “Uniform Format for Disclosure of Competing Interests in ICMJE Journals” and upload it on the Web site of the PAGEPress journal your work is involved with or email it back to us, in mind to allow PAGEPress to peer-reviewing your work. The document is in Adobe format, it includes instructions to help authors provide the requested information and the completion procedure is user-friendly. Kindly note that the format have to be completed and signed by each author of the work. We remain waiting for the completed form to proceed with publication. Please be informed that if this Disclosure Form is missing, we will not be able to publish your work.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.

Original Article(s)

3500 words max, abstract 180 words max, 30 references max, 3/5 tables and/or figures: In general, this kind of publication should be divided into an Abstract, Introduction, Materials and Methods, Results, Discussion, Conclusions and References.
A maximum of 10 authors is permitted and additional authors should be listed in an ad hoc Appendix.

Review Article(s)

4000 words max, abstract 250 words max, minimum 40 references, 3/5 tables and/or figures: They should be introduced by a general summary of content in the form of an Abstract. Following a short introduction, putting the study into context and defining the aim, reviews will concentrate on the most recent developments in the field. A review should clearly describe the search strategy followed (key words, inclusion, exclusion criteria, search engines, ...). No particular format is required; headings should be used to designate the major divisions of the paper

Brief Report(s)

About 2000 words, abstract 150 words max, 20 references max, 3 tables and/or figures: Short reports of results from original researches. They should be introduced by a general summary of content in the form of an Abstract. They must provide conclusive findings: preliminary observations or incomplete findings cannot be considered for publication.

Case report(s)

About 2000 words, abstract 150 words max, 20 references max, 3 tables and/or figures: Reports describing observations on clinical cases that can be educational, including adverse effects of drugs or outcomes of a specific treatment. They should be divided into: Abstract, Introduction (optional), Case report(s), Discussion, Conclusions and References.

Letters to the Editor

800 words max: These are written on invitation, short essays that express the authors’ viewpoint, may respond to published manuscripts in our journals, or deliver information or news regarding an issue related to the Journal scope. If the letter relates to a published manuscript, the authors of the original manuscript will be given the opportunity to provide a respond. Authors of Letters to the Editor should provide a short title.

Copyright Notice

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.

An Open Access Publication is one that meets the following two conditions:

  1. the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
  2. a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Privacy Statement

Privacy & Data Protection

This journal is published and managed by PAGEPress® srl (Pavia, Italy, VAT IT02125780185), which acts as the data controller for all personal data processed through this platform, in compliance with Regulation (EU) 2016/679 (GDPR).

Personal data collected through the editorial system (names, email addresses, affiliations, manuscript data, review records) is processed exclusively for the management of the peer review and publication workflow. We do not sell or share your data with third parties for marketing purposes.

For full details on data categories, legal bases, retention periods, your rights under GDPR, and how to exercise them, please read our complete Privacy Policy. Contact: office@pagepress.org.